Dapagliflozin vs Lumiracoxib

## Dapagliflozin vs Lumiracoxib: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Lumiracoxib**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Lumiracoxib — N/A.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Lumiracoxib — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Lumiracoxib — N/A.

**Type**: Dapagliflozin — Small molecule; Lumiracoxib — Small molecule.